Acadian Asset Management’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Acadian Asset Management’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-49,234	Closed	-$54K	–	2118
2019 Q1	$54K	Hold	49,234	–	–	﹤0.01%	1652
2018 Q4	$55K	Hold	49,234	–	–	﹤0.01%	1408
2018 Q3	$62K	Hold	49,234	–	–	﹤0.01%	1316
2018 Q2	$56K	Buy	49,234 +43,036	+694%	+$46K	﹤0.01%	1370
2018 Q1	$5K	Buy	+6,198	New	+$3.98K	﹤0.01%	1622
2015 Q2	–	Sell	-7,498	Closed	-$7K	–	1544
2015 Q1	$7K	Buy	+7,498	New	+$13.8K	﹤0.01%	1254

Other funds holding BDR

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Acadian Asset Management's BDR Position: Q2 2019 in Review

Acadian Asset Management sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2019, closing a stake of 49,234 shares — an estimated $54K sold.

Acadian Asset Management first reported a position in BDR in Q1 2015 and held it in 6 quarters. The position peaked at $62K in Q3 2018. 7 funds tracked by Wall St. Rank hold BDR as of Q2 2019.

Acadian Asset Management reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2019 after selling out during the quarter.
Acadian Asset Management sold 49,234 Blonder Tongue Laboratories Inc shares in Q2 2019, an estimated $54K.
Acadian Asset Management first reported a position in Blonder Tongue Laboratories Inc in Q1 2015 and held it in 6 quarters.
Acadian Asset Management's Blonder Tongue Laboratories Inc position peaked at $62K in Q3 2018.
7 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2019.

Based on Acadian Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.